Phosphate adsorbing agent for blood processing, blood processing system and blood processing method

Patent metadata

Field	Value
Publication number	US-11224871-B2
Application number	US-201816614066-A
Country	US
Kind code	B2
Filing date	May 17, 2018
Priority date	May 17, 2017
Publication date	Jan 18, 2022
Grant date	Jan 18, 2022

Abstract

The present invention provides a phosphate adsorbing agent for blood processing comprising a porous formed article comprising an organic polymer resin and an inorganic ion adsorbent and having a most frequent pore size of 0.08 to 0.70 μm measured with a mercury porosimeter, the phosphate adsorbing agent for blood processing having a biocompatible polymer in the surface of the porous formed article.

First claim

The invention claimed is:

1. A phosphate adsorbing agent for blood processing comprising a porous formed article comprising an organic polymer resin and an inorganic ion adsorbent and having a most frequent pore size of 0.08 to 0.70 μm measured with a mercury porosimeter, the porous formed article comprising a surface,
the phosphate adsorbing agent for blood processing having an ultrathin membrane of a biocompatible polymer in the surface of the porous formed article,
wherein the biocompatible polymer is poly(methoxyethyl acrylate), and
wherein a depth of a superficial layer corresponding to the surface of the porous formed article is equal to the attenuated total reflection-infrared spectroscopy measurement region which is a region within 1 μm from the surface.

2. The phosphate adsorbing agent for blood processing according to claim 1 , wherein the phosphate adsorbing agent is configured so that a ratio of an amount of phosphate adsorbed to the phosphate adsorbing agent for blood processing to an amount of phosphate adsorbed to the porous formed article is 1.01 or more.

3. The phosphate adsorbing agent for blood processing according to claim 1 , wherein an outer surface opening ratio of the porous formed article is 5% or more and less than 30%.

4. The phosphate adsorbing agent for blood processing according to claim 1 , wherein a specific surface area measured with a mercury porosimeter, of the porous formed article is 10 to 100 m 2 /cm 3 .

5. The phosphate adsorbing agent for blood processing according to claim 1 , wherein a ratio of the most frequent pore size to the median size measured with a mercury porosimeter, of the porous formed article is 0.80 to 1.30.

6. The phosphate adsorbing agent for blood processing according to claim 1 , wherein the porous formed article is spherical particles having an average particle size of 100 to 2500 μm.

7. The phosphate adsorbing agent for blood processing according to claim 1 , wherein the inorganic ion adsorbent contains at least one metal oxide represented by the following formula (I):
MN x O n .m H 2 O  (I)

wherein x is 0 to 3, n is 1 to 4, m is 0 to 6, and M and N are different from each other and each represent a metal element selected from the group consisting of Ti, Zr, Sn, Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Al, Si, Cr, Co, Ga, Fe, Mn, Ni, V, Ge, Nb and Ta.

8. The phosphate adsorbing agent for blood processing according to claim 7 , wherein the metal oxide contains at least one material selected from any of the following groups (a) to (c):
(a) hydrous titanium oxide, hydrous zirconium oxide, hydrous tin oxide, hydrous cerium oxide, hydrous lanthanum oxide and hydrous yttrium oxide,
(b) a mixed metal oxide of at least one metal element selected from the group consisting of titanium, zirconium, tin, cerium, lanthanum and yttrium, and at least one metal element selected from the group consisting of aluminum, silicon and iron, and
(c) activated alumina.

9. The phosphate adsorbing agent for blood processing according to claim 1 , wherein the organic polymer resin contains at least one component selected from the group consisting of an ethylene vinyl alcohol copolymer (EVOH), polyacrylonitrile (PAN), polysulfone (PS), polyethersulfone (PES) and polyvinylidene fluoride (PVDF).

10. A blood processing system comprising a phosphate adsorbing agent for blood processing according to claim 1 .

11. The blood processing system according to claim 10 , further comprising a blood purifier.

12. The blood processing system according to claim 11 , wherein the phosphate adsorbing agent for blood processing is disposed such that blood processed by the blood purifier is processed by the phosphate adsorbing agent for blood processing.

13. The blood processing system according to claim 11 , wherein the phosphate adsorbing agent for blood processing is disposed such that blood processed by the phosphate adsorbing agent for blood processing is processed by the blood purifier.

14. A blood processing method comprising phosphate adsorption including processing blood using a phosphate adsorbing agent for blood processing according to claim 1 .

15. The blood processing method according to claim 14 , comprising:
blood purification including processing blood using a blood purifier; and
the phosphate adsorption step before and/or after the blood purification.

Assignees

• Asahi Kasei Medical Co Ltd

Inventors

• Morita Naoki
• Tajima Hiroshi
• Kogawa Masashi

Classifications

• B01J47/04

  Mixed-bed processes · CPC title

• B01J20/28059

  being less than 100 m2/g · CPC title

• A61M1/3486

  Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents · CPC title

• B01J41/13

  obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds · CPC title

• A61M1/3679 Primary

  by absorption (A61M1/3675 takes precedence) · CPC title